Elisabeth Bendstrup

Research interests

Publications

• A new paradigm is needed to explain long COVID

  The Lancet Respiratory Medicine · 2023 · 10.1016/s2213-2600(22)00501-x

• Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

  JAMA · 2023 · 10.1001/jama.2023.5355

• Global incidence and prevalence of idiopathic pulmonary fibrosis

  Respiratory Research · 2021 · https://doi.org/10.1186/s12931-021-01791-z

• Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)

  European Respiratory Review · 2020 · 10.1183/16000617.0287-2020

• Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis

  New England Journal of Medicine · 2020 · 10.1056/nejmoa1913590

• Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

  American Journal of Respiratory and Critical Care Medicine · 2020 · 10.1164/rccm.202007-2794oc

• Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation

  European Respiratory Journal · 2020 · 10.1183/13993003.01760-2019

• Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

  American Journal of Respiratory and Critical Care Medicine · 2020 · https://doi.org/10.1164/rccm.202005-2032st

• Managing the supportive care needs of those affected by COVID-19

  European Respiratory Journal · 2020 · 10.1183/13993003.00815-2020

• Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

  American Journal of Respiratory and Critical Care Medicine · 2019 · 10.1164/rccm.201810-1891oc

• Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

  Current Medical Research and Opinion · 2019 · 10.1080/03007995.2019.1647040

• Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

  Respiratory Research · 2019 · 10.1186/s12931-019-1076-0

• Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

  Journal of Clinical Medicine · 2019 · 10.3390/jcm8122038

• Palliative care in interstitial lung disease: living well

  The Lancet Respiratory Medicine · 2017 · 10.1016/s2213-2600(17)30383-1

• A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211138

• Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study

  The Lancet Respiratory Medicine · 2016 · https://doi.org/10.1016/s2213-2600(16)30033-9

• Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial

  The Lancet Respiratory Medicine · 2016 · 10.1016/s2213-2600(16)30044-3

• Idiopathic Pulmonary Fibrosis – Diagnosis and Treatment

  General Medicine Open Access · 2014 · 10.4172/2327-5146.1000161

• How does comorbidity influence survival in idiopathic pulmonary fibrosis?

  Respiratory Medicine · 2014 · 10.1016/j.rmed.2014.01.008

• Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

  Advances in Therapy · 2014 · 10.1007/s12325-014-0112-1

• A cohort study of interstitial lung diseases in central Denmark

  Respiratory Medicine · 2013 · 10.1016/j.rmed.2013.09.002

• Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease

  The Journal of Heart and Lung Transplantation · 2012 · https://doi.org/10.1016/j.healun.2011.11.020

Current projects

No projects listed.